Perfuze has developed multiple neurovascular catheters receiving 510(k) and CE Mark approval for its zipline access catheter, and is in an active IDE study for its super-bore aspiration catheter. Perfuze closed its Series A investment round of €22.5M in 2022 bringing total capital raised to ~€35M and is being clinically tested in a 180-patient, 20-site, U.S. pivotal trial in pursuit of FDA approval for the thrombectomy catheter. Perfuze is hiring two Therapy Development Managers.
We have partnered with Wayne Allen, CEO, to hire our Therapy Development Manager. This position will be responsible for driving awareness and patient enrollment for IDE study while proctoring cases alongside neurosurgeons or interventional neurologists or radiologists. There are 20 identified clinical sites that are mostly located east of the Mississippi River. These positions must come from a neurovascular medical device background and being in proximity to a major airport is crucial due to the 50%-75% travel.
***Must have neurovascular medical device experience working in cath labs***
Bachelor’s degree or relevant technical training/certification required
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland and is a medical device company developing next-generation “super-bore” catheter technology to treat ischemic stroke. The founders have over 30 years combined MedTech experience within start-up and large corporations and are committed to bringing devices to market that have the potential to transform the treatment of acute ischemic stroke.
We develop devices intended to increase the rate of the First Pass Effect underpinned by:
Co-founder & CEO
Co-founder & CTO
Lifeblood™ supports global MedTech Startups with Talent Acquisition and Fundraising Strategies. We build full-scale startup teams from Board and C-level executives to entry-level individual contributors and from early-stage R&D through multi-national commercialization phases.Approaching two decades of experience in the MedTech industry, our talent acquisition services and team-building efforts are the results of 2,000+ successful hires for 500+ companies in 6 continents. We have facilitated more than $220 million for MedTech startups with our fundraising strategies and global investor network.
People and money are the lifeblood capital of startups. Learn from our entrepreneurs and investors as we demystify raising and investing capital on our MedTech Money Podcast Series.